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ABSTRACT 
  
 Carbon Nanotubes have attracted great attention since their discovery with their 
uniqueness based on outstanding mechanical, electronic and structural properties they 
have and wide application potential they promise. The significant properties of carbon 
nanotubes accumulated the studies on CNT-based electro analytical sensor applications. 
Although there is a huge amount of work on implementing CNTs for electrochemical 
studies, their implementation in optical biosensor platforms remains to be discovered. 
 Therefore, this study focuses on the Multi-Walled Carbon Nanotube 
implementation for optical biosensor platforms. The MWNTs were firstly 
functionalized via a two-step process of diimide-activated amidation and both the 
functionalized MWNTs and the protein immobilization on them were characterized with 
Dynamic Light Scattering, Fourier Transform Infrared Spectrometry and Scanning 
Electron Microscopy analysis. In order to explore the sensitivity enhancement that 
carbon nanotubes promise for immunosensor and oligonucleotide-sensor applications, 
microarray experiments in which functionalized MWNTs were used as a new 
microarray substrate were performed. MWNT coated slides enhanced the signal 
intensities of constructed platforms approximately 2 folds when antibodies were used as 
probe biomolecules with a lowest detection limit of 1,9 ng/ml. The signal enhancement 
served by the MWNT coted surfaces was 3 folds when oligonucleotides were used as 
probe biomolecules with a lowest detection limit of 1 nM. Also this MWNT coated 
slides and protein immobilization on them were further characterized via Scanning 
Electron Microscopy and Atomic Force Microscopy analysis.  
 The performed microarray experiments together with the other characterization 
studies, suggest functionalized MWNTs as good candidates for optical sensor platforms 
combining the benefits of increased surface area of 3D carbon nanotube structures, high 
binding capacity of MWNTs for biomolecules without changing their biologically 
active conformation, and the generation of a high signal to noise ratio according to the 
excellent low auto fluorescence of MWNTs. 
 . 
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ÖZET 
  
 Karbon Nanotüpler önemli mekanik, elektronik ve yapısal özelliklerinden 
kaynaklan eşsizlikleri ve gen,ş uygulama alanları sayesinde büyük ilgi toplamışlardır. 
Taşıdıkları bu önemli özellikler, özellikle son yıllarda karbon nanotüp temelli elektro 
analitik sensör çalışmalarının sayısının artmasını sağlamıştır. Her ne kadar karbon 
nanotüplerin elektrokimyasal sensör uygulamalarında kullanılması konusunda oldukça 
fazla çalışma olsa da, optik temelli biyosensör çalışmalarında kullanılmaları halen 
keşfedilmeyi beklemektedir. 
 Bu bağlamda, bu çalışma çok duvarlı karbon nanotüplerin optik biyosensör 
sistemleri için kullanılmasını içermektedir. Öncelikle, çok duvarlı karbon nanotüpler iki 
basamaklı bir amidasyon yöntemiyle işlevsellendirilmiş ve hem işlevsellendirilmiş çok 
duvarlı karbon nanotüler, hem de bu nanotüpler üzerinde yapılan protein 
immobilizasyonu DLS, FTIR ve SEM analizleri ile karakterize edilmiştir. Çok duvarlı 
karbon nanotüplerin optik antikor sensörleri ve oligonükleotid sensörleri için vaat 
ettikleri hassasiyet artırımını araştırmak için işlevsellendirilmiş nanotüp yapılarının 
substrat olarak kullanıldığı mikroarray deneyleri yapılmıştır. Yapılan bu deneylerde, 
nanotüpler ile kaplanan yüzeyler antikor arrayleri için sinyal seviyelerini yaklaşık iki 
kat, oligonücleotid arrayleri için ise yaklaşık üç kat arttırmıştır. Ayrıca, 
işlevsellendirilmiş çok duvarlı karbon nanotülerle hazırlanan bu yüzeyler ve bu yüzeyler 
üzerindeki protein immobilizasyonu SEM ve AFM metodları ile karakterize edilmiştir. 
 Yapılan mikroarray deneyleri ve diğer karakterizasyon çalışmaları 
işlevsellendirilmiş çok duvarlı karbon nanotüleri sundukları üç boyutlu yüzey, 
biyomolekülleri aktif konformasyonlarını kaybetmeden güçlü şekilde bağlayabilmeleri 
ve yüksek sinyal- parazit oranı sağlayan düşük oto-ışınımları sonucunda optik sensor 
platformları için güçlü adaylar olarak göstermektedir.  
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I. ITRODUCTIO 
 
1.1  BIOSESORS 
A biosensor is an analytical device that recognizes the presence of the species of 
interest and converts it into an electrical signal. A biosensor must include typically three 
major parts which are the target; the biosensing probe, which is able to recognize the 
target; and the transducer which will convert the presence of the target into an 
electrochemical signal. Application area of biosensors is really wide and some examples 
can be food and agricultural product safety, medical diagnostics, military applications as 
chemical and biological agent detection, etc. Biosensors emerge as promising tools for 
both laboratory and in-field applications. The first biosensor, a glucose sensor was 
developed by Clark and Lyons in 1962 [1]. 
1.1.1 Classification of Biosensors 
Classification of biosensors can be made according to either the biosensing 
element or the transducer. According to the biosensing element, there are three types of 
biosensors; first one is biocatalysis-based biosensors, which use enzymes as their 
biosensing elements; second is cell-based biosensors, which use whole-cells or 
microorganisms as biosensing elements; and the last one is bioaffinity-based biosensors, 
which compose the focus of this research and will be mentioned in more detail. 
Bioaffinity-based biosensors use either antibodies or oligonucleotides as their sensing 
elements. The ones involving antibodies, so called immunosensors, the mechanism of 
action is based on the specific interaction between an antibody and its antigen. And the 
ones involving nucleotide structures as the biosensing element, so called 
oligonucleotide- sensors or dna-sensors, the mechanism is based on the specific 
interaction between the oligonucleotide strand and its complementary strand. Although 
they are more complex than the other biosensing systems, they promise more selectivity 
and more specificity.  
According to the transducer type, biosensors can be classified in four different 
groups.  
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Fig 1.1. Schematic & Classification of Biosensor Systems.  
1.1.1.1 Electrochemical Transducers 
Electrochemical Transducers use a chemical change as the input parameter, and 
outputs it as an electrical signal which must proportional to the input. There are many 
different examples of electrochemical transducers, and most commonly used ones are 
described below.  
The sensors which are based on the measurement of the potential difference 
between the working electrode and the reference electrode are called Potentiometric 
Sensors. A logarithmic relation bared by the target analyte is used to calculate the 
generated potential. Although these transducers promise a wide detection limit, their 
requirement for a very stable reference electrode limits their usage. Amperometric 
sensors are based on the detection of the current change due to the oxidation or 
reduction at the working electrode. The output is generated with the linear proportion 
between the generated current and the concentration of the present analyte. Like in the 
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potentiometric transducers, the requirement for a stable reference electrode sets a barrier 
to their usability. Another example for electrochemical transducers can be 
Conductometric sensors, which generate the output from a logarithmic function derived 
from the change in the ionic strength of the working electrode have similar advantages 
and disadvantages with other electrochemical detection systems [2]. 
 1.1.1.2 Piezo-electric Transducers 
These biosensors are composed of microbalances based on piezoelectric crystals, 
where a decrease of the resonance frequency is correlated to the mass accumulated on 
its surface. These crystals are referred as quartz crystal microbalances (QCM). The 
potential of piezoelectric devices for chemical sensor applications was realized by 
Sauerbrey [3], who derived the following equation describing the frequency-to-mass 
relationship: 
 
The equation clearly indicates that the oscillating frequency is linearly dependent on the 
change in mass of adsorbed material at the crystal surface. To give some examples of  
these sensors, surface flexure plate wave (FPW), acoustic wave (SAW), shear 
horizontal surface acoustic wave (SH-SAW), thickness shear mode (TSM) sensors can 
be listed. 
 1.1.1.3 Enthalpymetric Transducers 
 These sensors are based on the measurement of generated heat change which is 
directly related with the concentration of the present analyte on the sensor surface. 
Therefore, enthalpymetric sensors are also referred as calorimetric or thermal biosensors 
[4]. 
 1.1.1.4 Optical Transducers 
 Optical sensor systems have been the oldest and the most widely used 
transducers for biosensor platforms. Optical transducers can use several types of 
detection methods, but the common property of each is that the transduced signal will 
be generated from light. For example, Absorption Transducers measure of intensity of 
absorbed or reflected light on the sensor platform, the principle of these systems is 
based on the Lambert-Beer law, which indicates a linear proportion between the 
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concentration of the analyte present and the measured absorbance. As another example, 
Luminescence Sensors measure the luminescence response upon UV excitation. These 
sensors can detect mainly two types of luminescence, first one is bioluminescence 
which will be generated by a living organism and the other one is chemiluminescence 
which will be generated by a chemical reaction. One other example, Fluorescence 
Sensors involves the measurement of fluorescence response upon excitation. And the 
last example, Surface Plasmon Resonance (SPR) technique is based on the 
measurement of the change in the refractive index of the sensor surface generated when 
the target molecules bind to the surface [5]. 
1.1.2 Challenges in Biosensor Technologies 
 There are five key steps in biosensor development. Firstly, the architecture of the 
planned sensor must be designed and constructed as one of the transducer types 
mentioned below. Fabrication method which can be either screen printing or 
microfabrication is the second step. The third step consists of the decision of the 
material that will be used as the probe or in other words as the biosensing element. After 
the probe is decided, method of immobilization must be determined, which can include 
adsorption, entrapment, microencapsulation, covalent attachment, etc. The last step is 
signal processing [6].  
 The developed biosensor systems must satisfy several criteria as sensitivity and 
specificity, potential for continuous monitoring, rapidity in response, inexpensive 
production, user-friendly, stability and reproducibility, easy to manufacture, 
compactness, etc. In spite of the past and current large amount of research in biosensor 
development, there is still a challenge to create improved and more reliable devices. 
There are many completed and still going- on research studies exist to improve either 
one or some of the criteria mentioned above. General improvement strategies are tried 
to be classified and explained with their key considerations below. 
 Firstly, there is a growing tendency toward miniaturization of analytical 
systems, since it reduces the reagent consumption, allows the easy handling of samples 
with lower volumes, and increases sample throughput [7]. Miniaturization can create 
less expensive, easy to handle devices, which will be especially important for in- field 
analysis. 
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  Production of inexpensive sensors not only needs miniaturization, but also 
requires batch-fabrication. Automated manufacturing technologies are required for the 
commercial production of large numbers of inexpensive, reproducible biosensor devices 
[8]. The need of clinical markets for large biosensor amounts can only be enabled with 
mass fabrication methods.  
 Lastly, the state- of-art technologies include improving bio-sensing interfaces, 
design and analysis on the molecular level. All are addressing bio-interfaces in 
molecular dimensions and thus can be summarized by the term “molecular 
nanotechnology” [9]. Therefore, there is a trend toward the combination of physics and 
biology in the creation of new nanostructures. Nanotechnology comprises a group of 
emerging techniques from physics, chemistry, biology, engineering, and 
microelectronics that are capable of manipulating matter at nanoscale. Nanotechnology 
promises to bridge the gap between materials science, coming from the micrometer 
range, and biochemistry- chemistry, where individual molecules are of the major 
interest [10].  
1.2 MICRO-ARRAY TECHOLOGIES 
 Both for DNA and proteins, microarrays provide a powerful analytical tool for 
the simultaneous analyses of thousands of parameters in a single experiment. As 
described in Ekins et al., microarray technologies was first applied for immunological 
ligand-binding assays and quickly draw attention with the improved sensitivity and 
high- throughput results that it provides compared to other techniques [11]. Microarray 
techniques are then widely used for DNA as diagnostic tools, aiming mostly to identify 
gene expression levels and single nucleotide polymorphisms (SNPs) [12, 13]. Also, 
micro-array based assays are used to characterize the proteome [14, 15]. Both protein 
and DNA based micro-arrays find application in wide areas like medical applications to 
toxicology studies. They are also able to provide information about the response of a 
cell to a specific substrate or even profiling the protein expression differences in a cell 
caused by a specific condition of interest. Furthermore, with the developed living cell 
micro-arrays, their usage provides information about the interaction of live cells with 
the interested biomolecules. [16, 17] 
 Microarrays are produced with the immobilization of high density biologically 
proper probes as discrete arranged spots. A microarray can serve up to 107 spot sites in 
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100mm2 areas ready for testing [18]. The DNA, protein, oligonucleotide or 
carbohydrate samples which will be used as the probe molecules are immobilized on a 
solid surface in a patterned manner by using spotting, contact printing or 
photolithography. The immobilized molecules are then become ready to capture the 
target molecules through specific interactions. The detection principle can vary, but 
many of the commercially available microarrays make use of fluorescent labels and 
fluorescent detection, through existing alternative labeling strategies as well as label-
free detection methods are also being developed. And finally, the acquired data is 
analyzed with the help of bioinformatics tools. 
 
Fig 1.2. Applications of Protein Microarrays [88]. 
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1.2.1 DA Micro-arrays 
 In spotted DNA micro-arrays, the immobilized probes can be small PCR product 
fragments, cDNA, oligonucleotides. Each of the probes will have a different sequence 
structure which will specifically recognize the sequence of interest. DNA micro-arrays 
are formed with spotting these probes onto the microarray substrate in an array format. 
Once the probes are spotted on the surface, they become ready for further hybridization 
with their complementary cDNA or cRNA targets derived from medical or experimental 
samples. These arrays can be adapted or customized to different experiments easily, 
because it allows the researchers to manipulate the set of chosen probes and printed 
array locations for each probe. They can also synthesize the probes themselves; label 
their own target sequences for hybridization. If the researchers have appropriate 
equipment, they can even print and scan the arrays themselves. This provides a 
relatively low cost analysis compared to other techniques and some commercially 
available arrays [19]. Application area of DNA micro-arrays is really wide, covering 
gene expression analysis, comparative genomic hybridization, chromatin 
immunoprecipitation, SNP detection, alternative splicing analysis, etc. 
1.2.2 Antibody Micro-arrays 
 As mentioned above, microarray technology and genomics serves opportunities 
to analyze a huge number of oligonucleotide samples in a single experiment and 
investigate the expression change of interested mRNA products in the cell in a specific 
condition. Although this is a really important analysis, the mRNA expression in a cell 
does not always correlate with the expression level of the protein that this specific 
mRNA is responsible for. This concept calls for the need of protein arrays, to be able to 
analyze protein expression change in a cell as a response to the interested specific 
conditions [20]. The most common type of these mentioned analytical protein arrays are 
antibody microarrays in which antibodies that bind specific antigens are arrayed on a 
glass slide at high density like in DNA-array experiments.  Then a lysate is passed over 
the prepared array and the bound antigen is detected after washing steps.  
1.2.3 State of Art: Problems & Achievements 
 Micro-array technologies have captured great attention with their high-
throughput results and distinct opportunities that they serve for analyzing very high 
numbers of protein–protein or compound–protein interactions simultaneously with a 
high dynamic range and low detection limits. However, their high-throughput capability 
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is directly dependent on the   ability to immobilize a certain number of spots with 
different receptors on a limited area. For supplying high spot densities, piezo-electric, 
ring and pin arrayers serve technological solutions. Just like in the case of affinity 
biosensors, more important concept seems to be the design of the micro-array surface 
which has to attain some requirements like, high immobilization density of receptors, 
adequacy of keeping immobilized biomolecules in an active state, adequacy of 
inhibiting nonspecific adsorption, adequacy of limiting matrix effects of complex 
biological solutions on the qualitative and quantitative specific detection of interested 
target. 
 In the beginning of array fabrication, firstly the probes must be attached to a 
solid surface which must have maximum binding capacity for the indented probe. The 
probes, either oligonucleotides or proteins, immobilized on the surface with a 
attachment substrate layer. This layer can vary corresponding to different types of 
probes and applications. A huge variety of materials are studied and being studied 
including porous polyacrylamide hydrogels, other hydrogel- like hydrophilic polymers, 
polyaminoacids [21], dextran-based hydrogel [22], and agarose [23]. A practical method 
for attachment of the probes is using nitrocellulose-membrane or poly-L-Lysine coated 
glass, on which probes can be passively immobilized on the surface through non 
specific interactions [24, 25, and 26]. The disadvantages of these methods are the 
random immobilization of the probes to the surface and high noise to signal ratio 
because of the non- specific interactions. Suggesting a more stronger and specific 
immobilization, glass substrates with reactive chemical groups is a more suitable 
method for probe immobilization in micro-array technologies. These chemical groups 
interact with the chemical groups on the probe and covalently cross-link the probes on 
the surface [27, 28]. Usually a bifunctional silane chemical cross-linker is used to form 
a SAM on the surface. This silane bind to the hydroxyl groups on glass and another 
group stays free to react with primary amine groups of the interested probes or it can 
also be further modified to have maximum specificity for the interested probes [29, 30].  
 This research proposes Multi-wall Carbon Nanotubes as surfaces for biosensor 
platforms and investigates their characteristics as micro-array substrates. Carbon 
Nanotubes are unique structures and they have attracted great attention since their 
discovery. Their uniqueness bases on their outstanding mechanical, electronic and 
structural properties. Their application potential covers a wide range from electronics, 
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microscopy, and composite materials to chemical and biological sensing. Most of these 
applications are close to experimental realization. However, acquired pristine carbon 
nanotubes are far away from being able to implement on the mentioned application 
areas. They need further chemical functionalizations to get involved in application 
plans. The functionalization of carbon nanotubes is a hot research topic as different 
chemical functionalizations of the nanotubes extends the scope of their application 
spectrum.  
1.3 CARBO AOTUBES 
1.3.1 Structure of Carbon anotubes 
 Carbon nanotubes (CNTs) which can be described as cylindrical molecules or 
chemical structures are formed by rolled up graphite sheets of hexagonal carbon that are 
capped by pentagonal carbon rings. Carbon has the ground state configuration of 2s2, 
2p2 with having four electrons in its outer valence shell. Three types of hybridizations 
are possible to occur in carbon: sp, sp2 and sp3. Diamond and graphite, two natural 
crystalline forms of pure carbon have sp3 and sp2 hybridizations, respectively. Carbon 
nanotubes have dominant sp2 and a small amount of sp3 hybridized carbon atoms [31]. 
Therefore, CNTs have two types of bonds. Along the cylinder wall, the in-plane σ 
bonds form the hexagonal network. The out-of-plane π-bonds are responsible for the 
weak van der Waals interaction between the layers in MWCNTs, and between 
MWCNTs or SWCNTs in the bundles. However, curvature produces a local strain in 
the π–ring systems [32]. 
                                
Fig 1.3. Multi- walled & Single- walled Carbon Nanotubes, respectively. 
 There are mainly two types of carbon tubes: Single-walled carbon nanotubes 
(SWCNTs) and Multi-walled carbon nanotubes (MWCNTs). SWCNTs are rolled up 
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from a single graphene sheet where the wall of the resultant nanotube is a single layer 
with closed ends. The nanotubes are classified as either having a zigzag, armchair or a 
chiral structure depending on the manner the graphene sheet is rolled up. SWCNTs have 
diameters of typically 1 nm with the smallest diameter reported to date being 0.4 nm. 
MWCNTs are a stack of graphene sheets rolled up into concentric cylinders with a layer 
spacing of 0.3-0.4 nm. MWCNTs tend to have diameters in the range 2-100 nm [33]. 
The unique structure of CNTs leads to a number of unusual properties in these 
materials. MWCNTs are regarded as metallic conductors [34]. SWCNTs are a mixture 
of metallic and semiconducting material, depending sensitively on their geometrical 
structures [35]. 
1.3.2 Production & Purification 
 Methods such as electric arc discharge, which involves the growth of CNTs on 
carbon (graphite) electrodes during the direct current arc-discharge evaporation of 
carbon in the presence of an inert gas such as helium or argon, laser vaporization in 
which a piece of graphite target is vaporized by laser irradiation under high temperature 
in an inert atmosphere and chemical vapor deposition techniques are well established 
and most widely used to produce the wide variety of MWCNTs. 
 Electric arc discharge, which involves the growth of CNTs on carbon (graphite) 
electrodes during the direct current arc-discharge evaporation of carbon in the presence 
of an inert gas such as helium or argon [36], is the easiest and most common method of 
producing CNTs. In Laser Vaporization Method, a piece of graphite target is vaporized 
by laser irradiation under high temperature in an inert atmosphere. MWNTs were found 
when a pure graphite target was used [37]. Other widely used method, chemical vapor 
decomposition (CVD), has been used for many years to produce carbon fibers. 
Therefore, it is a well- known and a more optimized production technique when 
compared to other widely used techniques. CVD involves the decomposition of a 
hydrocarbon in the presence of a catalyst and was first used in 1993 by Yacaman et al. 
& in 1994 by Ivanov et al. & Amelinckx et al. to produce MWCNTs [38, 39 and 40]. 
 As-synthesized CNTs prepared by the above methods inevitably contain 
carbonaceous impurities and metal catalyst particles, and the amount of the impurities 
commonly increases with the decrease of CNT diameter. To fulfill the vast potential 
applications and to investigate the fundamental physical and chemical properties of 
  24 
CNTs, highly efficient purification of the as-prepared CNTs is, therefore becomes an 
important concept. Purification methods involve different chemical and physical 
methods which will not be discussed further here [41]. 
1.3.3 Properties of Carbon anotubes 
 Depending on the crystal structure of the graphene sheets, CNTs can be metallic 
or semiconducting. The electronic transport occurs directly in metallic nanotubes. This 
allows the nanotubes to conduct electricity with minimal resistance [42]. For example in 
copper, the maximum current conductivity is 59.6x106 S/m [43]. Bulk MWNTs 
produced by arc discharge method have the conductivity ~ 100 S/cm , or 104 S/m [44], 
annealed multi-walled nanotubes, produced by chemical vapor deposition method have 
the conductivity 2x105 S/m [45]. High mechanical and chemical stability of carbon 
nanotubes is also a promising and outstanding property that CNTs serve. In terms of 
tensile strength and elastic modulus, carbon nanotubes are one of the strongest materials 
yet discovered; tensile strength of a typical SWNT is 56 times that of a steel wire and 
1.7 times that of silicon carbide nanorods [46]. 
 
Table 1.1. Evaluated properties of carbon nanotubes [35] 
Property Evaluation 
Maximal supported electrical current density 
 
~100 times greater than for copper wires 
Thermal conductivity >diamond 
Tensile strength ~100 times the strength of steel 
Young’s modulus stiffer than any other material 
Carrier mobility >hole mobility in Si 
 
  
 Also, corresponding to their size and chemical composition, properties of carbon 
nanotubes offers them to be used in medical and biological studies. The physical 
interaction between nanotubes and bacterial cell walls promises the potential use of 
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carbon nanotubes in microbiology studies [47]. Nanotubes can also penetrate the lipid 
bilayer of microbial cells, and allow release of intracellular contents through the 
artificial pore [48]. To focus on the subject of this study, the remarkable sensitivity that 
CNT conductivity brings in the surface proposes the use of CNT as highly sensitive 
nanoscale sensors. These properties make CNT extremely attractive for a wide range of 
electrochemical biosensors ranging from amperometric enzyme electrodes to DNA- 
biosensors. 
1.3.4 Functionalization of Carbon anotubes 
 Carbon nanotubes have attracted great attention because of their unique 
structural, electronic, mechanical and thermal properties. The incorporation of CNTs 
into different chemical, electrical and biological systems will surely enhance the 
thermal and mechanical properties of these systems [49]. However, the realization of 
nanotube-reinforced systems can only be achieved by solving following main problems. 
The atomically smooth nonreactive surface of nanotubes that is built of rolled graphene 
sheets and the poor dispersion of nanotubes in the many solvents limit the potential 
utilization of carbon nanotubes in many application areas [50]. In addition to that, 
because of the fine size and high surface energy of CNTs, with intrinsic van der Waals 
forces, bare CNTs were apt to aggregate and entangle together spontaneously. These 
problems can be overcome by using different functionalization methods for carbon 
nanotubes which can provide multiple bonding sites to the organic/ inorganic reactants 
[51]. The dispersion and solubility of CNTs in a solvent depends on the type and 
concentration of the functional chemical groups or molecules adsorbed on the tube 
surface. In this study, a covalent functionalization approach is used, therefore more 
information about covalent functionalization of CNTs will be provided. 
 The covalent functionalization of CNTs allows functional groups to be attached 
to tube end or side walls. Dissolution of CNTs in organic solvents requires the 
introduction of a hydrophobic substituent onto the carboxylic groups. Functionalization 
with different amines has been widely investigated to obtaining soluble CNTs, via 
covalent bonds [52-54], ionic bonds [53, 55, and 56] and physisorbed amines [57, 58]. 
The first report to form soluble SWCNTs using octadecylamine (ODA) was made by 
Chen et al [59]. They found that the functionalized tubes are soluble in a variety of 
organic solvents, such as chloroform, dichloromethane, benzene, chlorobenzene, 1,2-
dichlorobenzene, and carbon disulfide. Further studies showed that direct thermal 
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mixing of oxidized SWCNTs and alkylamines forms ion pairs [53], which are soluble in 
common organic solvents.  
 This ionic bond can be changed by introducing other organic and inorganic 
cations. Electrostatic interactions between CNTs and biological molecules are then 
possible, and these can serve as the basis for developing biocompatible CNTs. 
SWCNTs functionalized by esterification with pentanol enable the tubes to dissolve into 
some organic solvents [60]. The photochemical behavior of soluble alkyl ester-modified 
nanotubes gave rise to measurable photocurrents after illuminating solutions of these 
tubes. As well, the transient spectrum of the charge separated state was detected [61]. 
1.3.5 Applications of Functionalized Carbon anotubes 
 The modification of CNTs has attracted considerable attention over the past 
decade so, with several hundreds of papers published on the subject; the methods and 
substrates used to modify CNTs appears to be almost solely limited by the imagination 
of the scientists. 
 The applications of functionalized CNTs are increasing with the use of 
promising structural and physicochemical properties of modified CNTs, which can be 
grouped as electrochemical applications of modified CNTs for electroanalysis [62], 
bioelectroanalysis, [63] and the applications of modified CNTs for biomedical [64] and 
other bioanalytical applications [65]. Carbon nanotubes can be utilized within 
widespread applications, such as molecular electronics, transportation of drugs and 
genes, preparation of blends with polymers, electroluminescent devices, even as 
scaffolds for cell growth. For example, embedding carbon nanotubes in polymeric 
matrices for various nanocomposite materials has been a popular subject in the 
nanotube research [66, 67]. Results from the experimental preparation and fabrication of 
polymeric carbon nanocomposites based on pristine carbon nanotubes suggest that the 
dispersion of the nanotubes in polymer matrices is a challenging task. This is a 
particularly serious issue for nanocomposites that are designed for optical applications 
because the aggregation of carbon nanotubes, among other problems, reduces the 
optical quality of the composite materials. 
 To focus on an application area, the significant potential biological applications 
of carbon nanotubes have already attracted much attention. For example, Tsang et. al. 
reported the immobilization of oligonucleotides and many other studies reported the 
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immobilization of enzymes, and proteins on MWNTs [68]. Balavoine and co-workers 
used MWNTs for helical crystallization of proteins to take advantage of their shape and 
exceptional rigidity [69]. Mattson, Haddon, and co-workers also reported on the growth 
of embryonic rat-brain neurons on MWNTs [70]. The biocompatibility of carbon 
nanotubes is a significant issue in many of their proposed bio-applications. For the 
preparation of nanotube- protein bioconjugates, specifically, the different salvation and 
other requirements for the handling of bioactive molecules and for the processing of 
carbon nanotubes represent significant challenges [71].  
 
Fig 1.4. Applied Strategies Involving CNTs in Sensor Instrumentation [89].  
 Many other recent studies report about the electrochemical reactivity 
enhancement which carbon nanotubes provide to important biomolecules [72, 73]. This 
makes CNTs excellent candidates for electrochemical sensor implementations. In 
addition to this electrochemical reactivity enhancement, CNT-modified electrodes have 
been shown successful in  accumulating important biomolecules [74] and alleviating 
surface fouling effects which promise for the potential use of CNTs not only in 
electrochemical but also in optical sensor instrumentations. 
1.4 CT-BASED IMMUOSESOR & DA-SESOR STUDIES  
 Although there is a huge amount of work on CNT- based enzyme sensors, they 
have been less widely used for the design of affinity biosensors.  Interesting examples 
about CNT-based DNA-sensors and immunosensors will be mentioned below. 
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Recently, a label-free immunosensor for total prostate-specific antigen (T-PSA) using 
SWCNTs-array-modified Pt microelectrodes has been reported. The interaction between 
the T-PSA antigen and the T-PSA monoclonal antibody which is covalently 
immobilized on SWCNTs increase the oxidation of tyrosine and tryptophan residues, 
and the constructed sensor detects this enhanced oxidation. The detection limit for T-
PSA was enhanced with the use of SWNTs on the electrode [75]. Another example 
reports an amperometric immunosensor for the detection of carcinoembryonic antigen 
(CEA) which is constructed with layer-by-layer assembly of gold nanoparticles–
MWCNTs-thionine–Chit multilayer films on SAM-modified gold electrodes [76]. 
 One other example presents an electrochemical immunosensor for cholera toxin 
(CT) using poly(3,4-ethylenedioxythiophene)- coated CNTs and liposomes. Detection 
of CT is achieved with the labels which include ganglioside (GM1)-functionalized and 
potassium ferrocyanide encapsulated liposomes. The probe responsible for capturing 
CT was a monoclonal antibody against the β-subunit of CT which is also linked to poly 
(3,4-ethylenedioxythiophene) coated MWCNTs on a GCE. The experimental set-up was 
consisted of a sandwich-type assay, where the toxin is first bound to the anti-CT 
antibody and then to the GM1-functionalized liposome which then leads to 
electrochemical oxidation of potassium ferrocyanide. The oxidation was then measured 
by square wave voltammetry [77]. One of the recent works suggest a covalently bound 
anti-biotin antibodies embedded into a polylysine (PLL)-SWCNT composite layer 
coupled with an amperometric transducer. The system composed of covalently linked 
PLL, SWNTs and anti-biotin antibodies on the surface which enables both the enhanced 
detection of HRP labelled biotin and the enhanced thermal stability of the sensor [78]. 
Finally, as a last example, Yun et.al used EIS and cyclic voltammetry for 
characterization of antigen binding to anti-mouse IgG which is covalently immobilized 
on CNTs.and to measure different concentrations [79].  
 Concerning DNA-sensor development with the use of CNTs, for the 
electrocatalytic oxidation of guanine, β-cyclodextrin-incorporated CNTs-modified 
electrodes have proved their usefulness, which make very low detection limits like 10 
ng/ml DNA possible [80]. An example, an electrochemical sensor design showed the 
catalytic ability of MWCNTs for the direct electrochemical oxidation of guanine or 
adenine residues of ssDNA and adenine residues of RNA, leading to indicator-free 
detection of ssDNA and RNA. Proposed method can be used in detecting calf thymus 
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ssDNA in 5 minutes of hybridization time [81]. Another example makes use of binding 
event between Escherichia coli single strand binding protein (SSB) and ss-DNA 
causing an intrinsic oxidation of guanine residues. The system consists of ss-
oligonucleotides immobilized on a SWNT modified electrode which causes a decreased 
voltametric signal when it binds to SSB [82]. Also, use of MWCNTs-modified graphite 
pencil electrodes in DNA– sensors is presented in which the system is based on the 
enhancement of guanine signal using differential pulse voltammetry [83]. 
 To detect salmon sperm DNA, CNTs onto graphite electrodes were used. The 
constructed system reached a detection limit of 0.252nM for double-stranded salmon 
sperm DNA with the enhancements in electro active surface and heterogeneous electron 
transfer provided by the CNTs on the surface [84]. Also, a DNA-sensor which is able to 
detect complementary sequence at 5.0 x 10-6 µM was reported. The sensor was prepared 
with MWCNTs as GCE modifiers [85]. Another study showed the detection of 
complementary DNA strand with DNA probe immobilized on paste electrode 
assembled by MWCNTs. The sensor detects the current change appears with the 
hybridization to the complementary sequence in which oxidation peak current was 
linearly related to the logarithm of the concentration of the complementary DNA 
sequence [86]. As a last example, a sensitivity enhanced DNA-biosensor was 
constructed by using palladium nanoparticles in combination with MWNTs which are 
dispersed in nafion. This combination was used to modify GCE, on which probe 
oligonucleotides were covalently attached to the carboxylic groups of MWCNT [87]. 
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2. AIM of THIS STUDY 
 Biosensors allow the detection of defined biomolecules simultaneously with 
high dynamic range and low detection limits. Especially for the optical biosensor 
systems, high-throughput capability is directly dependent on the ability to immobilize a 
certain number of probes (biomolecules) on a limited area. In this aspect, designing the 
biosensor surface, which has to attain some requirements such as high immobilization 
density of probes, adequacy of keeping immobilized biomolecules in an active state, 
adequacy of inhibiting nonspecific adsorption, adequacy of limiting matrix effects of 
complex biological solutions, containing the biomolecule of interest is crucial. 
 This study aims to implement functionalized MWNTs as new surfaces for 
optical biosensor applications. Although there is a huge amount of work based on the 
electrochemical studies including CNTs, their implementation on optical biosensors 
remains to be discovered. Besides the electro catalytic ability of CNTs-modified 
electrodes, their enhanced active surface area and the anti-fouling capability of the 
modified surfaces promise enhancement effects on optical systems, which this study 
aims to discover. High binding capacity of MWNTs for biomolecules without changing their 
biologically active conformation is presented as well as a low auto fluorescence which 
is very important in order to generate a high signal to noise ratio in optical sensor 
systems are studied. Microarray experiments present MWNTs as good candidates for 
optical sensor platforms combining the benefits of increased surface area of 3D carbon 
nanotube structures with the excellent low auto fluorescence of carbon nanotubes as a 
black substrate. 
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3. MATERIALS & EXPERIMETAL  
3.1 Reagents 
 MWNTs (Baytubes®) with purity > 95%, length 1-5 µm and diameter 30±10 nm 
which are synthesized by CVD were obtained as a free sample from Bayer 
MaterialScience (Leverkusen, Germany) and used without further purification. Carboxy 
and Hydroxy functionalized MWNTs with purity > 95%, length 4-5 µm and diameter 20 
nm were purchased from Arry Nano materials and Nanotechnology (Hong Kong, 
China).  1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and 3-
aminopropyltriethoxy silane (APTES) were from Sigma-Aldrich. -
hydroxysuccinimide (NHS) was obtained from Aldrich. All other reagents and 
chemicals were of analytical grade and obtained from Sigma–Aldrich (St. Louis, MO). 
Water used for preparation of aqueous solutions was from a Millipore Direct-Q Water 
system (resistivity, 18 MΩ cm−2). All chemicals and reagents were used as-received 
without further purification. 
3.2 Functionalization of Carbon anotubes 
3.2.1 Carboxyl Functionalization of Baytubes
® 
 A suspension of 10 mg of Baytubes® was sonicated in a sonicator bath at room 
temperature for 12 hours in a 40 ml mixture of 3:1 (v/v) 98% H2SO4 and 70% HNO3. 
The contents were allowed to cool and sufficient time was given to let the nanotubes to 
settle down. The supernatant was discarded and the filtrate was extensively washed with 
de-ionized water and filtered by centrifugation until the pH of the solution was 7. The 
filtrate was then freeze dried and a dark solid product of MWNT-COOH was obtained.  
3.2.2 Functionalization of CTs with EDC/HS 
 8 mg of freshly oxidized MWNTs were suspended in 5 mL of deionized water 
by sonicating the mixture for 2 hours with a sonicator tip. Then, 1 mL of 500 mM MES 
buffer solution, pH 6.1 and 2.3 ml of a 50 mg/mL aqueous solution of NHS were added 
to the above suspension. Under fast stirring, 1.2 mL of freshly prepared 10 mg/mL 
aqueous solution of EDC was, and the mixture was stirred continually at room 
temperature for 2 hours. The suspension was filtered by centrifugation several to 
remove excess EDC, NHS and the by-product urea. If they will not be directly used for 
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protein immobilization, the filtrate was re-suspended in 10ml ddH2O and labelled as 
8X_MWT_HS. 
 
Fig 3.1. Covalent Immobilization of Antibodies on MWNT surface. 
3.2.3 Functionalization of CTs with APTES 
 8 mg of oxidized MWNT were suspended in 10% APTES by heating the 
solution to 60°C for 6 hours followed by stirring at room temperature for 3 hours. 
APTES modified MWNTs were recovered by centrifugation and rinsed thoroughly with 
water. 
 
Fig 3.2. Functionalization of CNTs with APTES. 
 
3.3 Protein Immobilization on Carbon anotubes 
 The activated CNTs were then re-dispersed in 9 mL of ddH2O, and 1 mL of a 
0.2 mg/mL CRP_Cap_Ab in PBS. After incubating the mixture on a platform shaker at 
4°C for 12 hours, the nanotube suspension was centrifuged at 13200 rpm and rinsed 
several times with water to remove any unbound protein. The protein- nanotube 
conjugate was finally suspended in 10ml ddH2O. A part of the sample was freeze dried 
for characterization studies. 
3.4 Characterization of Functionalized & Protein Immobilized Carbon anotubes 
3.4.1 Scanning Electron Microscopy (SEM) 
 Samples of functionalized and protein immobilized CNTs in solution were 
prepared by dropping a small amount of CNT solution on the sample holder and 
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allowed to air dry overnight. The samples were then coated with a thin layer of gold and 
imaged using a scanning electron microscope equipped with an energy dispersive X-ray 
analyzer (FEG-SEM Leo Supra 35, Oberkochen, Germany). 
 Preparation of the MWNT coated microarray substrate samples will be 
mentioned in section 3.5. For SEM imaging, the MWNT coated microarray substrate 
samples were coated with a thin layer of platinum and imaged using a JEOL JSM 7000F 
field emission scanning electron microscope equipped with an energy dispersive X-ray 
analyzer (JEOL, Tokyo, Japan), in Faculty of Chemical & Metallurgical Engineering, 
ITU. 
3.4.2 Fourier Transform Infrared Spectrometry (FT- IR) 
 Fourier transform infrared (FT-IR) spectra of functionalized samples were 
obtained on FTIR Spectrometer Bruker Equinox 55. 
3.4.3 Dynamic Light Scattering (DLS) 
 The hydrodynamic radii of the functionalized and protein immobilized MWNTs 
were determined by dynamic light scattering (DLS) measurements which were 
performed with a Zetasizer NanoZS (Malvern Instruments, Malvern, UK) using a 
He−Ne laser as a light source with λ = 632 nm. 
3.4.4. Atomic Force Microscopy (AFM) 
 The topology of the MWNT coated microarray substrate samples and protein 
immobilization on them was further analyzed by atomic force microscopy on an 
ambient AFM by Nanomagnetic Instruments (Oxford, UK). 
3.5 Coating Glass Slides with Functional Groups  
 Although commercial microarray slides are available, some other slides with 
different functional groups are also prepared. Firstly, the glass slides were etched at 
room temperature for overnight and rinsed with ddH2O. Then the slides were incubated 
in silaning solution including Ethanol, Acetic Acid and the desired silane chemical at 
room temperature for 10 hours. The slides were then washed extensively with 99% 
EtOH and ddH2O, and dried with nitrogen gun. 
3.6 Preparation of MWT Coated Microarray Substrates 
 Prepared 8X_MWT_HS solution was diluted to 4X-1/32X final 
concentrations using ddH2O. Slides were placed in micro plate microarray apparatus 
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and 90 µl of solution was delivered into wells. Coating was achieved after 24 hours 
incubation at room temperature on a shaker platform at 350 rpm. The slides were then 
washed extensively with ddH2O to remove loosely bound MWNTs on the surface. 
3.7 Microarray Experiments 
3.7.1 Antibody-arrays 
3.7.1.1 Antibody & Antigen Samples 
 Monoclonal antibody pairs and purified antigens for C- reactive protein, 
purchased from Fitzgerald Industries International (Concord, MA, USA). All of the 
antibody and antigen samples are stored at -20º C until used. 
3.7.1.2 Buffers 
 10 X PBS and Tween 20 were purchased from Sigma (USA). PBS-T (1 X PBS, 
0.5% Tween 20) and PBS (1 X) were used for all washing steps.  Protein Dilution 
Buffer (2% BSA in BPS-T) was used for dilution steps. Protein Printing and Protein 
Blocking Buffers were purchased from TeleChem International (Sunnyvale, CA, USA). 
3.7.1.3 Array Printing & Hybridization 
 All capture antibodies were diluted to desired final concentrations using Protein 
Printing Buffer. Capture antibodies were spotted at 70% relative humidity using SMP3 
pins, acquired from Telechem International and Omnigrid Accent Microarrayer 
(GeneMachine, San Carlos, CA, USA). Only one pin was used to ensure mechanical 
printing precision with agitated sonication-washing-drying cycles. Each antibody 
sample was spotted in triplicates. Spot diameter was 120 µm and space between spots 
for all dimensions was 500 µm. Spotted slides were incubated in humidity chamber 
providing >70% relative humidity for one hour. Slides were stored unprocessed at 4◦C 
and blocked with Protein Blocking Buffer for one hour just before the experiment. After 
one hour blocking, the slides were washed with PBS-T for 5 minutes, 1 X PBS for 10 
minutes and dried using the slide centrifuge.  
 Antigen samples were diluted to desired final concentration in Protein Dilution 
Buffer. Slides were placed in micro plate microarray apparatus and 70 µl of solution was 
delivered into wells. The incubation was done at room temperature for one hour on a 
rotating shaker at 350 rpm. After incubation, wells were rinsed five times with PBS-T 
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and 1 X PBS. Biotinylated detection antibody samples with 2µg/ml concentration were 
prepared in Protein Dilution Buffer and added to the wells. After 1-h incubation with 
detection antibodies, wells were washed as before. As a last step, slides were incubated 
for 30 minutes with Cy3 conjugated streptavidin at 2 µg/ml concentration in Protein 
Dilution Buffer to generate fluorescence signal from the sandwiched structure. After 
incubation, the slides were washed with PBS-T for 5 minutes, 1 X PBS for 10 minutes. 
They were then dried using slide centrifuge and stored in dark until scanning. 
 
Fig 3.3. Antibody Microarray Experimental Scheme. A- Capture Ab printing on the 
slides.  B-Antigen incubation. C- Biotinylated detection Ab incubation. D- Strep_Cy3 
incubation.   E- Scanning. F- Image Analysis. G- Data Analysis. 
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3.7.1.4 Image and Data Analysis 
 All slides were scanned under same exposure (0.2 s) in Cy3 channel with gain 
function “off” to obtain comparable images as manufacturer protocol suggested. About 
5 µm resolution was selected for all slides. Scanner software was used for the analysis 
of the obtained images. All of the data anlaysis and graphing were done with the 
software OriginPro®8. 
3.7.2 Oligo-arrays 
3.7.2.1 Oligonucleotide Samples 
  
QBP_38_F_1 
Sequence (5'-3'): GGT CCA CCA CCA TGG TTG CCA TAC ATG CCA CCA TGG 
TC 
 
QBP_38_F_2 
Sequence (5'-3'): GAC CAT GGT GGC ATG TAT GGC AAC CAT GGT GGT GGA 
CC 
 
QBP_38_R_1 
Sequence (5'-3'): TCC AGA CCA TGG TGG CAT GTA TGG CAA CCA TGG TGG 
TG 
 
QBP_38_R_2 
Sequence (5'-3'): CAC CAC CAT GGT TGC CAT ACA TGC CAC CATGGT CTG 
GA 
   
  
 Firstly, 5´ phosphate groups of all oligonucleotide samples were amine-
modified with an excess of ethylenediamine. Fig 3.4 shows the amine modification 
steps. 
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Fig 3.4. Amine-modification of Oligonucleotidea using Ethylenediamine, EDC, and  
Imidazole. 
  
 Then the oligonucleotides QBP_38_F_2 and QBP_38_R_2 which would be used 
as target samples are labeled with reactive fluorescent dyes of Cy5 and Cy3, 
respectively. All of the oligonucleotide samples are stored at -20º C until used. 
3.7.2.2 Buffers 
Stock Solutions 
4X Oligo- Printing Buffer [600 mM sodium phosphate pH 8.5] 
Dissolve the following in 90 ml of nuclease-free distilled water: 
  0.82 g Sodium phosphate monobasic (Sigma S0751) 
  7.57 g Sodium phosphate dibasic (Sigma S0876) 
 
Adjust the pH to 8.5 using 1 N NaOH or 1 N HCl. Bring the final volume to 100 ml 
with nuclease-free distilled water. 
Oligo- Blocking Solution [0.1 M Tris, 50 mM ethanolamine pH 9.0] 
Dissolve the following in 90 ml of nuclease-free double distilled water: 
  6.055 g Trizma Base (Sigma T6791) 
  7.88 g Trizma HCl (Sigma T6666) 
  3.05 g (3.0 ml) Ethanolamine (Sigma E9508) 
 
Adjust the pH to 9.0 using 6 N HCl. Bring final volume to 1 liter with double distilled 
water. 
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10% SDS 
Dissolve 100 g Sodium dodecyl sulfate into 900 ml of nuclease-free distilled water. 
(Also called sodium lauryl sulfate, Sigma L4522) Heat slightly to solubilize the solid. 
Adjust the pH to 7.2 by adding a few drops of 5 N HCl. Bring the final volume to 1 
liter. 
20X SSC 
Dissolve the following in 800 ml of nuclease-free distilled water: 
  175.3 g NaCl 
  88.2 g Sodium citrate 
 
Adjust the pH to 7.0 5 N NaOH. Bring the final volume to 1 liter. Sterilize by 
autoclaving.  
 
Post – Blocking Wash Solution 
  4X SSC, 0.1% SDS 
Oligo- Hybridization Buffer 
  2 X SSC, 0.1% SDS 
Post- Hybridization Wash Solutions 
      I.   2 X SSC, 0.1% SDS 
  II.  0.1 X SSC 
      III. 0 .01 X SSC 
3.7.2.3 Array Printing & Hybridization 
 All capture oligonucleotide probes were diluted to 100- 6.25 µM final 
concentration using Oligo- Printing Buffer. Oligonucleotide probes were spotted at 70% 
relative humidity using SMP3 pins, acquired from Telechem International and 
Omnigrid Accent Microarrayer (GeneMachine, San Carlos, CA, USA). Only one pin 
was used to ensure mechanical printing precision with agitated sonication-washing-
drying cycles. Each oligonucleotide probe was spotted in triplicates. Spot diameter was 
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120 µm and space between spots for all dimensions was 500 µm. Spotted slides were 
incubated in humidity chamber providing >70% relative humidity for overnight. Slides 
were stored unprocessed at 4◦C and blocked with pre- warmed Oligo- Blocking Solution 
for one hour just before the experiment. After one hour blocking, the slides were 
washed with pre- warmed Post– Blocking Wash Solution and dried using slide 
centrifuge.  
 Labeled oligonucleotide target samples were diluted to desired final 
concentration in Oligo- Hybridization Buffer. For the hybridization, LifterSlips are used. 
The LifterSlips are firstly cleaned with 100% EtoH and air dried. Then they are placed 
on the microarray slides, followed by pipetting the hybridization solution under the 
LifterSlips. The hybridization was carried out in a dark place at room temperature for 8 
hours. An appropriate amount of blank hybridization buffer is added inside the 
hybridization chamber to insure > 70% humidity throughout the incubation. After 
hybridization, the slides were washed with Post– Hybridization Wash Solutions I,II, and 
III, respectively. The slides were then dried using slide centrifuge and stored in dark 
until scanning. 
3.7.2.4 Image and Data Analysis 
 All slides were scanned with an ArrayWoRx(R) Biochip Reader (Applied 
Precision, Marlborough, UK) under same exposure (0.4 s) in Cy3 & Cy5 channels with 
gain function “off” to obtain comparable images as manufacturer protocol suggested. 
About 5 µm resolution was selected for all slides. Scanner software was used for the 
analysis of the obtained images. All of the data analysis and graphing were done with 
the software OriginPro®8. 
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4. RESULTS 
4.1 Dispersion of MWTs 
 A major barrier for developing and studying carbon nanotube based devices is 
the insolubility of CNTs in both aqueous and organic solvents and the resulting 
difficulty in processing them. Even the functionalized CNTs do not disperse in aqueous 
and organic solvents without assisting. The dispersion of CNTs can be assisted via two 
major approaches which are sonication and using surfactants as dispersing agents [90, 
91]. MWNT_COOH was dispersed in ddH2O by using the surfactant Triton X-100 and 
sonication. Fig 4.1.A shows the dispersion states reached via Triton X-100 and 
sonication. The best dispersion was reached with adding 0,1% Triton and 30 minutes 
sonication in a Bioblock Vibracell sonicator, so all of the dispersion steps were 
performed via this two step approach. Fig 4.1.B shows dispersed states of 
MWNT_NHS, MWNT_APTES, MWNT_COOH, and MWNT_OH. As seen the 
complete dispersion of MWNT_APTES in EtOH was not possible even via performed 
sonication and surfactant addition which is due to the high surface interaction between 
the APTES modified tubes [92]. 
 
 
Fig 4.1. Dispersion of MWNTs. (A) MWNT_COOH in ddH2O with no treatment (left), 
MWNT_COOH + Triton 100X (middle), MWNT_COOH + Triton 100X + Sonication 
(right). (B) MWNT_NHS in ddH2O, MWNT_APTES in EtOH, MWNT_COOH in 
ddH2O, MWNT_OH in ddH2O, from left to right, respectively. 
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4.2 Characterization of Functionalized MWTs 
4.2.1 Dynamic Light Scattering 
 The size distribution of functionalized MWNTs was analyzed by dynamic light 
scattering experiments. Size distribution of the MWNTs is also a key for characterizing 
the efficiency of different functionalization steps and the achieved dispersion. Fig 4.2 
shows the size distribution of MWNT_COOH purchased from Arry Nanotechnology, 
with 20 nm diameter just as mentioned by the producer. The peak corresponding to 
~4650 nm corresponds to the length of the MWNT_COOH. 
 
Fig 4.2. Size Distribution of MWNT_COOH purchased from Arry Nanotechnology. 
 Next steps of functionalization were also characterized via DLS. Fig 4.3. 
presents the EDC/ NHS treated oxidized Baytubes® (A) and the APTES modified 
MWNT_OH (B). Both of the functionalization steps are not totally successful as 
resulting in functional group attachment to a limited percentage of ~ 26% of the 
MWNTs. On the other hand, treatment of MWNT_COOH with EDC/ NHS resulted in 
MWNT_NHS with ~ 65 nm diameter with an intensity of 100% (Fig 4.4.). Therefore, 
MWNT_NHS functionalization was chosen for further protein immobilization and 
surface modification studies as the yield of this functionalization process was more than 
EDC/ NHS treatment of oxidized Baytubes® and the APTES modification of 
MWNT_OH. 
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A 
B 
Fig 4.3. Size Distribution of oxidized Baytubes® after EDC/ NHS treatment (A), and 
Size Distribution of APTES modified MWNT_OH (B). 
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Fig 4.4. Size distribution of EDC/ NHS treated MWNT_COOH, (MWNT_NHS). 
 Protein immobilization on MWNT_NHS was performed using CRP Antibody as 
the model protein as mentioned in Materials & Experimental section. The process 
resulted in an MWNT_Protein conjugate with a diameter of ~365 nm with a 94% yield. 
Only 6% of the MWNT_NHS was not able to bind CRP_Cap_Ab. 
 
 
Fig 4.5. Size distribution of CRP_Cap_ Ab immobilized MWNT_NHS.  
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4.2.2 Fourier Transform Infrared Spectrometry 
 Each modification step is characterized using FT-IR to probe the vibrational 
changes during adsorption of proteins. Fig 4.6. shows the FT-IR spectrum of the 
MWNT-COOH, MWNT-OH, MWNT-NHS, and protein immobilized MWNTs. The 
assignments of the peaks are presented in Table 4.1. The protein immobilization on the 
MWNTs was evident from the appearance of the amide absorption peak at 1090 cm-1. 
 
 
 
 
Fig 4.6. Transmission FTIR spectra of different functionalization steps. 
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Table 4.1. Assignment of the absorbencies in the FTIR spectra in Fig 4.1.                    
Assignment Wavenumber/cm-1 Reference 
O-H Stretching 3300 [93] 
H-bonded NH vibration 
band 
2360 [93] 
C= C Stretching 1625 [94] 
Succinimide Group 1200 [98] 
C-OH groups of serine, 
threonine, & tyrosine 
residues 
1172 [95] 
Protein Amide I Absorption ~1090 [96] 
Si-OH Groups 1016 [97] 
4.2.3 Scanning Electron Microscopy 
 SEM analyses were performed in order to further characterize the functionalized 
MWNTs. The predictable size of MWNT_NHS in the SEM image supports the DLS 
results. SEM image of MWNT_APTES shows non- homogenous functionalization of 
the nanotubes having different diameters, again supporting the DLS results indicating 
the low yield of the APTES functionalization (Fig 4.7.). 
Fig 4.7. SEM images of MWNT_NHS (A) and MWNT_APTES (B). 
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 Protein immobilization on MWNT_NHS is presented in Fig 4.8. It must be 
mentioned that imaging of MWNT_NHS at the same resolution as that of protein 
immobilized MWNTs was very difficult according to the change in conductivity on the 
surface of the MWNTs.  Immobilized proteins on the surface of MWNTs are clearly 
seen in the image. 
 
 
Fig 4.8. SEM images of MWNT- NHS before (A) and after protein immobilization (B). 
 
4.3 Microarray Experiments 
4.3.1 Antibody Arrays 
 Coating of the microarray slides with different MWNT_NHS concentrations was 
performed as mentioned in Section 3.6. A sandwich type microarray experiment was 
performed in order to decide on the optimal MWNT_NHS concentration on the surface 
yielding the highest signal intensities. 8 different CRP_Cap_Ab concentrations were 
tried with each MWNT_NHS concentration on every slide. Among all the slides having 
different functional groups on their surface, the amine slide coated with 
1/16X_MWT_HS and the mercapto slide coated with 4X_MWT_HS showed the 
highest intensities (Fig 4.9.). Therefore, 1/16X_MWT_HS coated amine slide and 
4X_MWT_HS coated mercapto slide were chosen for further experiments about the 
dynamic range of  immobilized CRP_Cap_Ab on MWNT_NHS coated slide surfaces. 
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Fig 4.9. (A) Experimental Design for the coating of the slides with different 
MWNT_NHS concentrations. (B) Signal Intensities of the Amine Slide resulted from 
different MWNT_NHS coating concentrations. (C) Signal Intensities of the Mercapto 
Slide resulted from different MWNT_NHS coating concentrations. 
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Fig 4.10. Comparative Standard Curves on bare and MWNT_NHS coated slides for 
2mg/ml and 0,25 mg/ml CRP_Cap_Ab concentrations.  
 
 Experiments for standard curve generation were performed by using serial 
dilutions of CRP antigen to determine the dynamic range of each CRP_Cap_Ab 
concentration on MWNT coated and non-coated microarray slides as mentioned in 
Section 3.7.1. Standard curves, presented in Fig 4.10 were calculated using spot 
intensity values after background subtraction. About 12 µm squares were selected from 
corners between spots on the slides for background calculations. Final spot intensities 
were calculated by subtracting reference spot intensity values from each antibody’s spot 
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intensity. “ Boltzmann Fit” parameter was used for  the standard curve analysis (Fig 
4.11.). R2 values for 1/16X_MWT_HS coated amine slide were calculated as 0.9819, 
0.9890, 0.9847, 0.9729, 0.9795, 0.9578, 0.9506 for  CRP_Cap_Ab concentrations of  2, 
1.5, 1, 0.75, 0.5, 0.25, 0.125mg/ml, respectively. 
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Fig 4.11. Boltzmann Regression Analysis of different CRP_Cap_Ab concentrations on 
1/16X_MWT_HS coated amine slide. (A) For CRP_Cap_Ab Concentration 2 mg/ml. 
(B) For CRP_Cap_Ab Concentration 1.5 mg/ml. (C) For CRP_Cap_Ab Concentration 1 
mg/ml. (D) For CRP_Cap_Ab Concentration 0.75 mg/ml. (E) For CRP_Cap_Ab 
Concentration 0.5 mg/ml. (F) For CRP_Cap_Ab Concentration 0.25 mg/ml. (G) For 
CRP_Cap_Ab Concentration 0.125 mg/ml. 
  
 
 
 R2 values for 4X_MWT_HS coated mercapto slide were calculated as 0.9312, 
0.9189, 0.9452, 0.9206, 0.9358, 0.9882, 0.9251 for  CRP_Cap_Ab concentrations of  2, 
1.5, 1, 0,75, 0,5, 0,25, 0,125mg/ml, respectively (Fig 4.12.). 
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Fig 4.12. Boltzmann Regression Analysis of different CRP_Cap_Ab concentrations on 
4X_MWT_HS coated mercapto slide. (A) For CRP_Cap_Ab Concentration 2 mg/ml. 
(B) For CRP_Cap_Ab Concentration 1.5 mg/ml. (C) For CRP_Cap_Ab Concentration 1 
mg/ml. (D) For CRP_Cap_Ab Concentration 0.75 mg/ml. (E) For CRP_Cap_Ab 
Concentration 0.5 mg/ml. (F) For CRP_Cap_Ab Concentration 0.25 mg/ml. (G) For 
CRP_Cap_Ab Concentration 0.125 mg/ml. 
 
 
 
4.3.2 Oligonucleotide Arrays 
 As mercapto and amine slides yielded the highest intensities in antibody arrays, 
they were chosen for further oligonucleotide array experiments. Coating of the 
microarray slides with different MWNT_NHS concentrations was again performed as 
mentioned in Section 3.6. And similar to the antibody arrays, the first microarray 
experiments was performed in order to decide on the optimal MWNT_NHS 
concentration on the surface yielding the highest signal intensities. Eight different Probe 
Oligonucleotide concentrations were tried with each MWNT_NHS concentration on 
mercapto and amine slides. This experiment indicated that the amine slide coated with 
1X_MWT_HS and the mercapto slide coated with 4X_MWT_HS revealing the 
highest intensities (Fig 4.13.). Therefore, 1X_MWT_HS coated amine slide and 
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4X_MWT_HS coated mercapto slide were chosen for further experiments about the 
dynamic range of  immobilized Probe Oligonucleotide Samples on MWNT_NHS 
coated slide surfaces. 
 
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
2x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
4 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/8 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/4x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/2 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
0 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/32 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/16 x
I
n
t
e
n
s
i
t
y 
L
e
v
e
l
Capture Ab Concentration (mg/ml) A
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
4x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
2 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/2 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
0x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/4 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/32 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/16 x
0
2000
4000
6000
2 1,5 1 0,75 0,5 0,25 0,125 0
1/8 x
I
n
t
e
n
s
i
t
y 
L
e
v
e
l
Capture Ab Concentration (mg/ml) B 
Fig 4.13. (A) Signal Intensities of the Amine Slide resulted from different 
MWNT_NHS coating concentrations. (B) Signal Intensities of the Mercapto Slide 
resulted from different MWNT_NHS coating concentrations. 
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Fig 4.14. Comparative Standard Curves on bare and MWNT_NHS coated slides for 
2µM and 0,25 µM Probe Oligonucleotide concentrations.  
 
 Experiments for standard curve generation were performed by using serial 
dilutions of Target Oligonucleotide samples to determine dynamic range of each probe 
Oligonucleotide concentration on MWNT coated and non-coated microarray slides as 
mentioned in Section 3.7.2. Standard curves, presented in Fig 4.14. were calculated just 
  59 
like in antibody array analysis. “Boltzmann Fit” parameter was used for  the standard 
curve analysis.  
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Fig 4.15. Boltzmann Regression Analysis of different Probe Oligonucleotide 
concentrations on 1X_MWT_HS coated amine slide. (A) For Probe Oligonucleotide 
Concentration 2 mg/ml. (B) For Probe Oligonucleotide Concentration 1.5 mg/ml. (C) 
For Probe Oligonucleotide Concentration 1 mg/ml. (D) For Probe Oligonucleotide 
Concentration 0.75 mg/ml. (E) For Probe Oligonucleotide Concentration 0.5 mg/ml. (F) 
For Probe Oligonucleotide Concentration 0.25 mg/ml. (G) For Probe Oligonucleotide 
Concentration 0.125 mg/ml. 
 
 R
2 values for 1X_MWT_HS coated amine slide were calculated as 0.9711, 
0.9453, 0.8553, 0.8908, 0.9192, 0.9839, 0.8682 for  Probe Oligonucleotide 
concentrations of  2, 1.5, 1, 0.75, 0.5, 0.25, 0.125 µM, respectively (Fig 4.15.). 
 R
2 values for 4X_MWT_HS coated mercapto slide were calculated as 0.9615, 
0.9735, 0.987, 0.9508, 0.9516, 0.9929, 0.8718 for  Probe Oligonucleotide 
concentrations of  2, 1, 1.5, 0.75, 0.5, 0.25, 0.125 µM, respectively (Fig 4.16.). 
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Fig 4.16. Boltzmann Regression Analysis of different Probe Oligonucleotide 
concentrations on 4X_MWT_HS coated mercapto slide. (A) For Probe 
Oligonucleotide Concentration 2 mg/ml. (B) For Probe Oligonucleotide Concentration 
1.5 mg/ml. (C) For Probe Oligonucleotide Concentration 1 mg/ml. (D) For Probe 
Oligonucleotide Concentration 0.75 mg/ml. (E) For Probe Oligonucleotide 
Concentration 0.5 mg/ml. (F) For Probe Oligonucleotide Concentration 0.25 mg/ml. 
(G) For Probe Oligonucleotide Concentration 0.125 mg/ml. 
 
 
4.4 Characterization of MWT Coated and Protein Immobilized Glass Slides 
4.4.1 Scanning Electron Microscope 
 The 1/16X_MWT_HS coated amine and 4X_MWT_HS coated mercapto 
slide surfaces were examined with SEM (Fig 4.17.). It must be mentioned that imaging 
of 1/16X_MWT_HS coated amine slide was very hard as it is poorly conductive 
when compared to 4X_MWT_HS coated mercapto slide. The lighter colored parts 
indicate the open functional groups ready for the protein or oligonucleotide attachment 
and they are clearly seen in all of the images. 
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Fig 4.17. SEM images of 1/16X_MWT_HS coated amine slide with different 
magnification factors (A, B, C) & SEM images of 4X_MWT_HS coated mercapto 
slide with different magnification factors (D, E, F). 
 
 
   
 
Fig 4.18. SEM images of 1/16X_MWT_HS coated amine slide (A) & 
4X_MWT_HS coated amine slide (B). 
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 Fig 4.19. SEM images of immobilized proteins on 1/16X_MWT_HS coated amine 
slide with different magnification factors. 
  
 In order to explain the signal reduction caused by higher MWNT_NHS 
concentrations on the surface, SEM analysis of 1/16X_MWT_HS coated amine slide 
and 4X_MWT_HS coated amine slide were performed (Fig 4.18.). The dense 
structure observed in 4X_MWT_HS coated amine slide presents thick MWNT_NHS 
coating on the surface blocking the sites on themselves for protein immobilization, 
therefore reducing the signal intensities. Protein immobilized surfaces are also 
examined with SEM. Fig 4.19. clearly shows the protein immobilization on 
1/16X_MWT_HS coated amine slide. It is also seen that MWNTs tied up the proteins 
which will result in enhancing their stability on the slide surface. 
4.4.2 Atomic Force Microscopy 
 The 4X_MWT_HS coated mercapto surface was examined with AFM before 
and after protein immobilization. Fig 4.20. indicates that the most of the MWNT_NHS 
are horizontally oriented on the surface, and their presence on the surface is clear with 
the undulating morphology. After protein immobilization, the height of the slide surface 
increases about 250nm indicating the presence of the proteins on the surface. 
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Fig 4.20. 3D- AFM image of 4X_MWT_HS coated mercapto slide. 
  70 
 
Fig 4.21. 3D- AFM image of 4X_MWT_HS coated mercapto slide after protein 
immobilization. 
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5. DISCUSSIO 
 
 Pristine carbon nanotubes were far away from being able to implement on 
application areas, firstly further chemical functionalizations were needed to achieve 
their dispersion in organic and inorganic solvents. Successful dispersion of the MWNTs 
was achieved with sonication and addition of Triton X-100 as a dispersant in every step. 
The applied covalent functionalization strategies in this work were examined and 
characterized with DLS, FTIR and SEM experiments. All of the characterization 
methods proposed EDC/NHS treatment of carboxyl functionalized MWNTs as the best 
functionalization process with the highest yield for chemical functionalization and best 
capability of protein binding among all. APTES modified MWNT_OH were not chosen 
for further experiments considering their low chemical functionalization yield and poor 
dispersion in aqueous solvents related to the high surface interaction between the 
APTES modified MWNTs. Also, MWNT_COOH purchased from Arry 
Nanotechnologies were preferred to carboxyl functionalized Baytubes® with the same 
reason of higher yield for chemical functionalization. This can be due to the low 
efficiency in carboxyl functionalization process of Baytubes® which can be further 
optimized by changing the sonication period and incubation temperature. Protein 
immobilization on MWNT_NHS is successfully achieved via EDC/NHS treatment of 
carboxyl functionalized MWNTs, as mentioned below and analyzed via SEM, where 
immobilized proteins on the surface of MWNT_NHS are clearly seen. 
 Next steps involved implementation of MWNT_NHS as new microarray 
substrates. After the microarray experiments which are planned on MWNT_NHS coated 
slides with different functional groups on them, 1/16X_MWT_HS coated amine slide 
and 4X_MWT_HS coated mercapto slide were chosen for further antibody array 
experiments where 1X_MWT_HS amine slide and 4X_MWT_NHS coated mercapto 
slide were chosen for oligonucleotide array experiments. Performed experiments 
showed the signal enhancement effects of MWNT_NHS on surface both for antibody 
and oligonucleotide arrays. These signal enhancements supports the hypothesis of this 
study which is making use of carbon nanotube properties like high binding capacity of 
them for biomolecules without changing their biologically active conformation and their 
low auto fluorescence, generating a high signal to noise ratio. The risk by the use of a 
3D surface instead of a 2D could be the loss of fluorescence intensity in the depth of the 
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surface structure. However, the results show that the depth fluorescence photons were 
coming from was in conformation with the standard depth of focus of commercial 
fluorescence scanner. A sigmoidal intensity increase as a function of fluorescent protein 
and oligonucleotide concentration was noticed for the MWNT substrate.  
 The characterization of the MWNT_NHS coated and protein immobilizied slides 
were also achieved via SEM and AFM analysis. The results confirm the efficient 
MWNT_NHS coating of the slide surfaces and presents the efficient protein 
immobilization on the surface of MWNT coated slides. To sum up, MWNT coated 
slides appeared to be good candidates as new substrates for antibody and 
oligonucleotide arrays after all the characterization experiments.  
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6. COCLUSIO & FUTURE REMARKS 
  
 This work includes a method of MWNT implementation for optical biosensor 
platforms. Covalent carbodiimide-activated amidation of the MWNTs were chosen as 
the best functionalization method for biomolecule immobilization. The characterization 
techniques confirmed the successful functionalization of MWNTs as well as the 
successful immobilization of biomolecules on the functionalized MWNT surfaces. 
Microarray experiments, in which MWNT_NHS was proposed as a new microarray 
substrate, were performed in order to characterize the dynamic range of immobilized 
probe biomolecules. Results of the designed microarray experiments suggest MWNTs 
as good candidates for optical sensor platforms combining the benefits of high binding 
capacity of MWNTs for biomolecules without changing their biologically active 
conformation, increased surface area of 3D carbon nanotube structures, and the 
excellent low auto fluorescence of MWNTs generating a high signal to noise ratio. 
 The unique physical and mechanical properties of carbon nanotubes make them 
ideal candidates for electroanalytical studies. Their enhanced active surface area, the 
anti-fouling capability of the modified surfaces and the electro catalytic ability promise 
their successful implementation also in other biosensing transducers, in addition to the 
optical systems which this work mainly focuses on. Therefore, future work includes 
implementation of functionalized MWNTs as a surface for capacitive biosensors. In 
addition to the enhancement effects of MWNTs suggested in this study for optical 
systems, their electro catalytic ability promise for their enhancements also in the 
capacitive biosensor platform which is being investigated in our laboratory. 
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APPEDIX A 
Data Sheets of Carbon anotubes  
 
 
Stock 
number 
-OH          
-COOH 
 
Diameter 
 
Purity 
 
Length Ash 
 
SSA 
 
ARQM003 -OH 
content: 
1~7wt% 
10-20nm >95wt% ＜20µm <1.5wt% >220 
m2/g 
ARSM003  -COOH 
content: 
1~6wt% 
10-20nm >95wt% ＜20µm <1.5wt% >200 
m2/g 
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APPEDIX B 
Data Sheets of Antibodies & Antigens  
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